ANIX

Anixa Biosciences Inc

NasdaqCM · Healthcare

$3.79

-8.59% today

1 insider bought $11.2K

Pro sees filings in ~15 min

Price

hover · 4 moves explained

10 buys22 8-K

Prices distorted

Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ANIX ever actually traded at. The drop is real, but those huge old numbers aren't.

Analyst consensus

Strong Buy

$11.00target+190.6%vs $3.79 today

$9.00 low today target$14.00 high

3 analysts · ~12-month consensus · as of May 27. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 3 of last 4

Earnings per share · actual vs forecast

Q3 '25+30.0%

−$0.07

exp −$0.10

Q4 '25

−$0.09

exp −$0.09

Q1 '26+11.1%

−$0.08

exp −$0.09

Q2 '26+30.0%

−$0.07

exp −$0.10

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Buy	2026-07-27	KUMAR AMIT	Chief Executive Officer	0.5%Direct	3,000	$3.73	$11.2K
Buy	2026-06-17	Titterton Lewis H jr	Director	0.3%Direct	2,836	$2.64	$7.5K
Buy	2026-06-16	KUMAR AMIT	Chief Executive Officer	3.3%Direct	21,000	$2.50	$52.5K
Buy	2026-01-29	Baskies Arnold M	Director	7.4%Direct	10,000	$3.04	$30.4K
Exercise	2025-12-16	Titterton Lewis H jr	Director	—Direct	16,000	$2.92	$46.7K

Buy

KUMAR AMIT

Chief Executive Officer · 0.5% of stake · 2026-07-27

$11.2K

3,000 @ $3.73

Buy

Titterton Lewis H jr

Director · 0.3% of stake · 2026-06-17

$7.5K

2,836 @ $2.64

Buy

KUMAR AMIT

Chief Executive Officer · 3.3% of stake · 2026-06-16

$52.5K

21,000 @ $2.50

Buy

Baskies Arnold M

Director · 7.4% of stake · 2026-01-29

$30.4K

10,000 @ $3.04

Exercise

Titterton Lewis H jr

Director · 2025-12-16

$46.7K

16,000 @ $2.92

8 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →